Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA06 - Challenges in the Treatment of Early Stage NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Florentino Hernando-Trancho, Ayten Kayi Cangir
-
+
MA06.07 - E1505: Adjuvant Chemotherapy +/- Bevacizumab for Early Stage NSCLC: Updated Chemotherapy Subset Analysis
14:05 - 14:10 | Presenter: Heather A Wakelee | Author(s): Suzanne E Dahlberg, Steven M Keller, William J Tester, Seena C Aisner, Jan M. Rothman, Jyoti D Patel, Robert Delaune, Sean R McDermott, Atif Shafqat, Roman Perez-Soler, Andrew E Chapman, Samer S Kasbari, Anne M Traynor, Tracey L Evans, Leora Horn, Stephen L Graziano, David R Gandara, Alex A Adjei, Charles A Butts, Natasha B Leighl, Suresh S Ramalingam, Joan H Schiller
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-109 - Phase II Trial of Pemetrexed/Carboplatin/Bevacizumab +/- Atezolizumab in NSCLC Patients That Are EGFR Mutated or Never Smoked
09:45 - 09:45 | Presenter: J. Nicholas Bodor | Author(s): Jyoti D Patel, Eric A Ross, Samuel Litwin, Joseph Treat
- Abstract
Loading... -
+
P1.01-127 - Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Joel W Neal, D. Ross Camidge, Alexander Spira, Zosia Piotrowska, Leora Horn, Daniel B Costa, Anne Tsao, Jyoti D Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, HOWARD WEST, Sylvie Vincent, Jian Zhu, Shu Jin, Steven Zhang, Shuanglian Li, Pasi A Jänne
- Abstract
Loading... -
+
P1.01-67 - Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC (HCRN LUN13-175): Outcomes by Nab-Paclitaxel Dose
09:45 - 09:45 | Presenter: Ryan D Gentzler | Author(s): Nisha Anjali Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser Hanna, Young Kwang Chae, Victoria Meucci Villaflor, Marianna Koczywas, Irene B Helenowski, Alfred W Rademaker, Jyoti D Patel
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-17 - Phase I/II Study of Nivolumab and Vorolanib in Patients with Refractory Thoracic Tumors
09:45 - 09:45 | Presenter: Leora Horn | Author(s): Jennifer G. Whisenant, Kathryn E Beckermann, Hossein Borghaei, Taofeek Owonikoko, Jyoti D Patel, Lynn D. Berry, Yu Shyr, Kim Harrow, Chris Liang, Allison Holzhausen, Giovanni Selvaggi, Heather A Wakelee
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.08 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
09:10 - 09:20 | Presenter: Alexander Drilon | Author(s): Geoffrey R Oxnard, Lori Wirth, Benjamin Besse, Oliver Gautschi, Shao Weng Daniel Tan, Herbert H. Loong, Todd Bauer, Yu Jung Kim, Atsushi Horiike, Keunchil Park, Manisha Shah, Caroline McCoach, Lyudmila Bazhenova, Takashi Seto, Marcia Brose, Nathan Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Yuichiro Ohe, Karen L Reckamp, Valentina Boni, Miyako Satouchi, Gerald S Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D Patel, Nehal Lakhani, Fabrice Barlesi, Mark Burkard, Viola W. Zhu, Victor Moreno, Jacques Medioni, Marc Matrana, Christian Rolfo, Dae Ho Lee, Hovav Nechushtan, Melissa Johnson, Vamsidhar Velcheti, Makoto Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lucy Song, Ji-Youn Han, Alexander Spira, Filippo Guglielmo Maria De Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara-Konishi, Saiama Waqar, Hirotsugu Kenmotsu, Frederick Wilson, Binoj Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Zhu, Michele Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, Stephen Michael Rothenberg, Benjamin J Solomon, Koichi Goto, Vivek Subbiah
- Abstract
Loading...
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.01 - Complex EGFR Mutations in Lung Adenocarcinoma
14:00 - 14:10 | Presenter: Shang-Gin Wu | Author(s): Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih
- Abstract
Loading... -
+
OA11.02 - Changes of Brain Structure in Advanced NSCLC Patients Receiving EGFR-TKIs: Dynamic Analysis Based on Series MRI Images
14:10 - 14:20 | Presenter: Chunli Luo | Author(s): Beisheng Yang, Xiaojuan Zhou, Lin Zhou, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
- Abstract
Loading... -
+
OA11.03 - Survival Disparities Between Academic and Community Centers in Advanced Lung Cancer in the US: Can We Bridge the Gap?
14:20 - 14:30 | Presenter: Sendilnathan Ramalingam | Author(s): Michaela Dinan, Jeffrey Crawford
- Abstract
Loading... -
+
OA11.04 - Discussant - OA11.01, OA11.02, OA11.03
14:30 - 14:45 | Presenter: Joel W Neal
- Abstract
No abstract available for this presentation
-
+
OA11.05 - Optimizing Resources with Immunotherapy in Developing Countries: Experience in a Reference Center in Mexico
14:45 - 14:55 | Presenter: Omar Eleazar Macedo-Perez | Author(s): Ivan Lyra Gonzalez, Leticia Bornstein, Katya Campos-Peralta, Jose Luis Aguilar-Ponce, Adan Gomez-Ponce, Angel Herrera-Gomez, Edgardo Jimenez-Fuentes
- Abstract
Loading... -
+
OA11.06 - Alternative Nivolumab (N) Duration and Scheduling in Advanced Non-Small Cell Lung Cancer (aNSCLC): Real-Life Data
14:55 - 15:05 | Presenter: Elizabeth Dudnik | Author(s): Mor Tal Moskovitz, Abed Agbarya, Teodor Kuznetsov, Tzippy Shochat, Damien Urban, Mijana Wollner, Alona Zer, Ofer Rotem, Nir Peled, Jair Bar
- Abstract
Loading... -
+
OA11.07 - Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for EGFR Mutation NSCLC Patients: Update Data for NCT02148380
15:05 - 15:15 | Presenter: Wei Zhang | Author(s): Jianlin Xu, Yuqing Lou, Yanwei Zhang, Baohui Han
- Abstract
Loading... -
+
OA11.08 - Discussant - OA11.05, OA11.06, OA11.07
15:15 - 15:30 | Presenter: Ullas Batra
- Abstract
No abstract available for this presentation
-
+
PC03 - Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy
- 15:45 - 17:15
- 9/09/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Targeted Therapy
- Moderators:James Chih-Hsin Yang, Elisa Gobbini
-
+
PC03.02 - CONs
16:05 - 16:25 | Presenter: Jyoti D Patel
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-12 - Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC
10:15 - 10:15 | Presenter: Jyoti D Patel | Author(s): Michael Jelinek, Christine M Bestvina, Sean Pitroda, Everett E. Vokes, Steve Chmura
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-12 - Tyrosine Kinase Inhibitor Resistance Mechanisms in EGFR T790M-Positive Lung Cancer: The University of Chicago Experience
10:15 - 10:15 | Presenter: Garth William Strohbehn | Author(s): Livia Szeto, Brittany Beach, Katelyn Edgington, Kirsteen Lugtu, Jeremy P Segal, Lauren Ritterhouse, Christine M Bestvina, Everett E. Vokes, Jyoti D Patel
- Abstract
Loading...